References
- TsertsvadzeAYazdiFFinkHAOral sildenafil citrate (Viagra) for erectile dysfunction: a systematic review and meta-analysis of harmsUrology200974483183619592078
- LiaJChangTWDetermination of transdermal sildenafil in nude mouse skin by reversed-phase high-performance liquid chromatographyJ Chromatogr B Biomed Sci Appl2001765216116611767309
- YonessiMSaeediMA Double-blind placebo-controlled evaluation of the effect of topical sildenafil on erectile dysfunctionJ Appl Res200552289294
- BadwanAANabulsiLAL-OmariMMSildenaf il citrateBrittainHGAnalytical Profiles of Drug Substances and ExcipientsNew YorkAcademic Press2001372376
- ShinHSBaeSKLeeMGPharmacokinetics of sildenafil after intravenous and oral administration in rats: hepatic and intestinal first-pass effectsInt J Pharm20063201–2647016730145
- NicholsDJMuirheadGJHarnessJAPharmacokinetics of sildenafil after single oral doses in healthy male subjects: absolute bioavailability, food effects and dose proportionalityBr J Clin Pharmacol200253 Suppl 1S512
- WangYChowMSZuoZMechanistic analysis of pH-dependent solubility and trans-membrane permeability of amphoteric compounds: application to sildenafilInt J Pharm20083521–221722418068319
- CevcGVierlUNanotechnology and the transdermal route: a state of the art review and critical appraisalJ Control Release2010141327729919850095
- ManjunathKVenkateswarluVPharmacokinetics, tissue distribution and bioavailability of clozapine solid lipid nanoparticles after intravenous and intraduodenal administrationJ Control Release2005107221522816014318
- MüllerRHRadtkeMWissingSASolid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparationsAdv Drug Deliv Rev200254 Suppl 1S13115512460720
- KüchlerSHerrmannWPanek-MinkinGGSLN for topical application in skin diseases: characterization of drug-carrier and carrier-target interactionsInt J Pharm2010390222523320153414
- PardeikeJHommossAMüllerRHLipid nanoparticles (SLN, NLC) in cosmetic and pharmaceutical dermal productsInt J Pharm20093661–217018418992314
- HanFLiSYinRShiXJiaQInvestigation of nanostructured lipid carriers for transdermal delivery of flurbiprofenDrug Dev Ind Pharm200834445345818401788
- UnerMWissingSAYenerGMüllerRHSkin moisturizing effect and skin penetration of ascorbyl palmitate entrapped in solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) incorporated into hydrogelPharmazie2005601075175516259122
- PugliaCFilosaRPedutoAEvaluation of alternative strategies to optimize ketorolac transdermal deliveryAAPS PharmSciTech2006736417025245
- FangJYFangCLLiuCHSuYHLipid nanoparticles as vehicles for topical psoralen delivery: solid lipid nanoparticles (SLN) versus nano-structured lipid carriers (NLC)Eur J Pharm Biopharm200870263364018577447
- HuFQJiangSPDuYZYuanHYeYQZengSPreparation and characteristics of monostearin nanostructured lipid carriersInt J Pharm20063141838916563671
- Schäfer-KortingMMehnertWKortingHCLipid nanoparticles for improved topical application of drugs for skin diseasesAdv Drug Deliv Rev200759642744317544165
- ElnaggarYSEl-MassikMAAbdallahOYSildenaf il citrate nanoemulsion vs self-nanoemulsifying delivery systems: rational development and transdermal permeationInt J Nanotechnol201188–9749763
- ShimHJLeeEJJungYHDetermination of a new phosphodiesterase V inhibitor, DA-8159, in plasma and urine by high-performance liquid chromatographyJ Pharm Biomed Anal200230352753312367677
- ElnaggarYSEl-MassikMAAbdallahOYSelf-nanoemulsifying drug delivery systems of tamoxifen citrate: design and optimizationInt J Pharm20093801–213314119635537
- Dragicevic-CuricNGräfeSGitterBWinterSFahrASurface charged temoporfin-loaded flexible vesicles: in vitro skin penetration studies and stabilityInt J Pharm20103841–210010819819321
- BarberoAMFraschHFPig and guinea pig skin as surrogates for human in vitro penetration studies: a quantitative reviewToxicol in Vitro200923111319013230
- TeeranachaideekulVSoutoEBJunyaprasertVBMüllerRHCetyl palmitate-based NLC for topical delivery of Coenzyme Q(10): development, physicochemical characterization and in vitro release studiesEur J Pharm Biopharm200767114114817346953
- KumarVVChandrasekarDRamakrishnaSKishanVRaoYMDiwanPVDevelopment and evaluation of nitrendipine loaded solid lipid nanoparticles: influence of wax and glyceride lipids on plasma pharmacokineticsInt J Pharm20073351–216717517161566
- JenningVGohlaSComparison of wax and glyceride solid lipid nano-particles (SLN)Int J Pharm2000196221922210699722
- Organisation for Economic Co-operation and Development Screening Information Data SetsSodium carbonateBostonUNEP publications2002 Available from: http://www.inchem.org/documents/sids/sids/Naco.pdfAccessed October 18, 2010
- ZhuangCYLiNWangMPreparation and characterization of vinpocetine loaded nanostructured lipid carriers (NLC) for improved oral bioavailabilityInt J Pharm201039417918520471464
- GodinBTouitouETransdermal skin delivery: predictions for humans from in vivo, ex vivo and animal modelsAdv Drug Deliv Rev200759111152116117889400
- SetoJEPolatBELopezRFBlankschteinDLangerREffects of ultrasound and sodium lauryl sulfate on the transdermal delivery of hydrophilic permeants: comparative in vitro studies with full-thickness and split-thickness pig and human skinJ Control Release20101451263220346994
- Radomska-SoukharevAStability of lipid excipients in solid lipid nanoparticlesAdv Drug Deliv Rev200759641141817553589